Healthcare provider profile · identity verified

Christopher J Conrad, MD

Family Practice · FORT WAYNE, IN · NPI 1386728863

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	912	256
Levothyroxine Sodium	Levothyroxine Sodium	622	151
Amlodipine Besylate	Amlodipine Besylate	409	114
Lisinopril	Lisinopril	406	124
Losartan Potassium	Losartan Potassium	404	120
Omeprazole	Omeprazole	396	114
Gabapentin	Gabapentin	362	94
Metformin Hcl Er	Metformin Hcl	359	109
Rosuvastatin Calcium	Rosuvastatin Calcium	243	77
Sertraline Hcl	Sertraline Hcl	238	69
Pantoprazole Sodium	Pantoprazole Sodium	227	66
Famotidine	Famotidine	193	69
Metformin Hcl	Metformin Hcl	183	52
Alprazolam	Alprazolam	167	28
Tamsulosin Hcl	Tamsulosin Hcl	165	46
Hydrochlorothiazide	Hydrochlorothiazide	157	45
Ozempic	Semaglutide	153	32
Montelukast Sodium	Montelukast Sodium	143	44
Buspirone Hcl	Buspirone Hcl	130	37
Carvedilol	Carvedilol	124	36
Duloxetine Hcl	Duloxetine Hcl	123	25
Bupropion Xl	Bupropion Hcl	122	39
Metoprolol Succinate	Metoprolol Succinate	121	38
Pravastatin Sodium	Pravastatin Sodium	119	34
Trazodone Hcl	Trazodone Hcl	116	30
Albuterol Sulfate Hfa	Albuterol Sulfate	112	46
Alendronate Sodium	Alendronate Sodium	111	28
Tramadol Hcl	Tramadol Hcl	111	22
Simvastatin	Simvastatin	106	30
Potassium Chloride	Potassium Chloride	92	31
Mounjaro	Tirzepatide	90	19
Allopurinol	Allopurinol	88	27
Jardiance	Empagliflozin	87	18
Ezetimibe	Ezetimibe	86	26
Fluticasone Propionate	Fluticasone Propionate	85	35
Escitalopram Oxalate	Escitalopram Oxalate	84	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	26
Furosemide	Furosemide	82	26
Meloxicam	Meloxicam	77	28
Glimepiride	Glimepiride	70	21
Metoprolol Tartrate	Metoprolol Tartrate	70	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	23
Fluoxetine Hcl	Fluoxetine Hcl	63	16
Atenolol	Atenolol	61	19
Venlafaxine Hcl Er	Venlafaxine Hcl	59	13
Olmesartan Medoxomil	Olmesartan Medoxomil	56	16
Pioglitazone Hcl	Pioglitazone Hcl	56	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Tizanidine Hcl	Tizanidine Hcl	50	27
Prednisone	Prednisone	48	39
Clopidogrel	Clopidogrel Bisulfate	47	16
Donepezil Hcl	Donepezil Hcl	47	11
Synthroid	Levothyroxine Sodium	46	12
Doxycycline Hyclate	Doxycycline Hyclate	43	36
Eliquis	Apixaban	43	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	41	suppressed
Cephalexin	Cephalexin	38	33
Farxiga	Dapagliflozin Propanediol	38	11
Glipizide Er	Glipizide	38	suppressed
Lovastatin	Lovastatin	38	suppressed
Symbicort	Budesonide/Formoterol Fumarate	38	suppressed
Pregabalin	Pregabalin	37	11
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	13
Valsartan	Valsartan	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	14
Lansoprazole	Lansoprazole	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	12
Spironolactone	Spironolactone	32	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Finasteride	Finasteride	31	11
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Amoxicillin	Amoxicillin	29	15
Tresiba Flextouch U-100	Insulin Degludec	29	11
Trulicity	Dulaglutide	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	12
Januvia	Sitagliptin Phosphate	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Topiramate	Topiramate	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Meclizine Hcl	Meclizine Hcl	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Tradjenta	Linagliptin	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Baclofen	Baclofen	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Glipizide	Glipizide	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Cefdinir	Cefdinir	16	16
Chlorthalidone	Chlorthalidone	15	suppressed
Colchicine	Colchicine	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Azithromycin	Azithromycin	14	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Linzess	Linaclotide	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Pen Needle	Pen Needle, Diabetic	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error